avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf16
|
ENSMUSG00000035397.8 | Kruppel-like factor 16 |
Sp8
|
ENSMUSG00000048562.6 | trans-acting transcription factor 8 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf16 | mm10_v2_chr10_-_80577285_80577327 | -0.82 | 1.1e-09 | Click! |
Sp8 | mm10_v2_chr12_+_118846329_118846329 | 0.04 | 8.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_84450944 | 14.05 |
ENSMUST00000085192.5
|
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr8_-_93131271 | 13.91 |
ENSMUST00000034189.8
|
Ces1c
|
carboxylesterase 1C |
chr1_+_72824482 | 11.93 |
ENSMUST00000047328.4
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr8_+_105269788 | 10.87 |
ENSMUST00000036127.2
ENSMUST00000163734.2 |
Hsf4
|
heat shock transcription factor 4 |
chr8_+_105269837 | 10.87 |
ENSMUST00000172525.1
ENSMUST00000174837.1 ENSMUST00000173859.1 |
Hsf4
|
heat shock transcription factor 4 |
chr6_-_85869128 | 10.22 |
ENSMUST00000045008.7
|
Cml2
|
camello-like 2 |
chr10_+_63024315 | 10.20 |
ENSMUST00000124784.1
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr10_-_88503952 | 10.13 |
ENSMUST00000020253.8
|
Chpt1
|
choline phosphotransferase 1 |
chr10_+_80329953 | 10.11 |
ENSMUST00000105358.1
ENSMUST00000105357.1 ENSMUST00000105354.1 ENSMUST00000105355.1 |
Reep6
|
receptor accessory protein 6 |
chr12_+_8771405 | 9.98 |
ENSMUST00000171158.1
|
Sdc1
|
syndecan 1 |
chr5_+_134986191 | 9.71 |
ENSMUST00000094245.2
|
Cldn3
|
claudin 3 |
chr12_+_108334341 | 9.05 |
ENSMUST00000021684.4
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr12_+_8771317 | 9.02 |
ENSMUST00000020911.7
|
Sdc1
|
syndecan 1 |
chr5_-_53213447 | 8.97 |
ENSMUST00000031090.6
|
Sel1l3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr11_+_94211431 | 8.57 |
ENSMUST00000041589.5
|
Tob1
|
transducer of ErbB-2.1 |
chr19_+_46131888 | 8.54 |
ENSMUST00000043739.3
|
Elovl3
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
chr7_+_44590886 | 8.45 |
ENSMUST00000107906.3
|
Kcnc3
|
potassium voltage gated channel, Shaw-related subfamily, member 3 |
chr1_+_133363564 | 8.25 |
ENSMUST00000135222.2
|
Etnk2
|
ethanolamine kinase 2 |
chr4_+_141368116 | 8.08 |
ENSMUST00000006380.4
|
Fam131c
|
family with sequence similarity 131, member C |
chr8_-_93079965 | 7.88 |
ENSMUST00000109582.1
|
Ces1b
|
carboxylesterase 1B |
chr9_+_47530173 | 7.42 |
ENSMUST00000114548.1
ENSMUST00000152459.1 ENSMUST00000143026.1 ENSMUST00000085909.2 ENSMUST00000114547.1 ENSMUST00000034581.3 |
Cadm1
|
cell adhesion molecule 1 |
chr11_-_120660565 | 7.34 |
ENSMUST00000106177.1
|
Notum
|
notum pectinacetylesterase homolog (Drosophila) |
chr10_+_128194446 | 7.22 |
ENSMUST00000044776.6
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr1_+_74332596 | 7.13 |
ENSMUST00000087225.5
|
Pnkd
|
paroxysmal nonkinesiogenic dyskinesia |
chr4_-_115496129 | 7.11 |
ENSMUST00000030487.2
|
Cyp4a14
|
cytochrome P450, family 4, subfamily a, polypeptide 14 |
chr10_-_88503912 | 6.95 |
ENSMUST00000117579.1
ENSMUST00000073783.5 |
Chpt1
|
choline phosphotransferase 1 |
chr4_+_97777780 | 6.76 |
ENSMUST00000107062.2
ENSMUST00000052018.5 ENSMUST00000107057.1 |
Nfia
|
nuclear factor I/A |
chr7_-_19749464 | 6.71 |
ENSMUST00000075447.7
ENSMUST00000108450.3 |
Pvrl2
|
poliovirus receptor-related 2 |
chr10_+_128194631 | 6.71 |
ENSMUST00000123291.1
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr14_-_61556746 | 6.68 |
ENSMUST00000100496.4
|
Spryd7
|
SPRY domain containing 7 |
chr17_-_32917048 | 6.68 |
ENSMUST00000054174.7
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr13_-_69611421 | 6.65 |
ENSMUST00000091514.5
|
Srd5a1
|
steroid 5 alpha-reductase 1 |
chr14_-_33447142 | 6.65 |
ENSMUST00000111944.3
ENSMUST00000022504.5 ENSMUST00000111945.2 |
Mapk8
|
mitogen-activated protein kinase 8 |
chr2_-_168741752 | 6.60 |
ENSMUST00000029060.4
|
Atp9a
|
ATPase, class II, type 9A |
chr4_-_129239165 | 6.52 |
ENSMUST00000097873.3
|
C77080
|
expressed sequence C77080 |
chr7_-_19692596 | 6.46 |
ENSMUST00000108451.2
ENSMUST00000045035.4 |
Apoc1
|
apolipoprotein C-I |
chr11_-_102296618 | 6.44 |
ENSMUST00000107132.2
ENSMUST00000073234.2 |
Atxn7l3
|
ataxin 7-like 3 |
chr13_-_17694729 | 6.42 |
ENSMUST00000068545.4
|
5033411D12Rik
|
RIKEN cDNA 5033411D12 gene |
chrX_-_85776606 | 6.39 |
ENSMUST00000142152.1
ENSMUST00000156390.1 ENSMUST00000113978.2 |
Gyk
|
glycerol kinase |
chr17_-_45686120 | 6.32 |
ENSMUST00000143907.1
ENSMUST00000127065.1 |
Tmem63b
|
transmembrane protein 63b |
chr9_+_46268601 | 6.21 |
ENSMUST00000121598.1
|
Apoa5
|
apolipoprotein A-V |
chr11_+_98348404 | 6.18 |
ENSMUST00000078694.6
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr4_+_117252010 | 6.14 |
ENSMUST00000125943.1
ENSMUST00000106434.1 |
Tmem53
|
transmembrane protein 53 |
chr1_-_121328024 | 6.13 |
ENSMUST00000003818.7
|
Insig2
|
insulin induced gene 2 |
chr7_+_24481991 | 6.12 |
ENSMUST00000068023.7
|
Cadm4
|
cell adhesion molecule 4 |
chr2_-_130642770 | 6.11 |
ENSMUST00000045761.6
|
Lzts3
|
leucine zipper, putative tumor suppressor family member 3 |
chr8_-_124751808 | 6.10 |
ENSMUST00000055257.5
|
Fam89a
|
family with sequence similarity 89, member A |
chr11_-_74925925 | 6.06 |
ENSMUST00000121738.1
|
Srr
|
serine racemase |
chr17_-_8148097 | 6.04 |
ENSMUST00000097420.5
|
Rnaset2a
|
ribonuclease T2A |
chr4_+_117251951 | 6.00 |
ENSMUST00000062824.5
|
Tmem53
|
transmembrane protein 53 |
chr7_+_44384604 | 5.97 |
ENSMUST00000130707.1
ENSMUST00000130844.1 |
Syt3
|
synaptotagmin III |
chr11_-_70700105 | 5.92 |
ENSMUST00000108543.3
ENSMUST00000108542.1 ENSMUST00000108541.2 ENSMUST00000126114.2 ENSMUST00000073625.1 |
Inca1
|
inhibitor of CDK, cyclin A1 interacting protein 1 |
chr9_+_55326913 | 5.87 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chr10_-_88504073 | 5.78 |
ENSMUST00000117440.1
|
Chpt1
|
choline phosphotransferase 1 |
chr4_-_148160031 | 5.76 |
ENSMUST00000057907.3
|
Fbxo44
|
F-box protein 44 |
chr16_-_24393588 | 5.76 |
ENSMUST00000181640.1
|
1110054M08Rik
|
RIKEN cDNA 1110054M08 gene |
chr11_+_101468164 | 5.74 |
ENSMUST00000001347.6
|
Rnd2
|
Rho family GTPase 2 |
chr7_-_100658394 | 5.68 |
ENSMUST00000138830.1
ENSMUST00000107044.3 ENSMUST00000116287.2 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr15_-_86033777 | 5.68 |
ENSMUST00000016172.7
|
Celsr1
|
cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) |
chr4_-_114908892 | 5.67 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr2_-_160872552 | 5.63 |
ENSMUST00000103111.2
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr17_+_32506446 | 5.58 |
ENSMUST00000165999.1
|
Cyp4f17
|
cytochrome P450, family 4, subfamily f, polypeptide 17 |
chr11_-_69369377 | 5.56 |
ENSMUST00000092971.6
ENSMUST00000108661.1 |
Chd3
|
chromodomain helicase DNA binding protein 3 |
chr8_+_70072896 | 5.56 |
ENSMUST00000110160.2
ENSMUST00000049197.5 |
Tm6sf2
|
transmembrane 6 superfamily member 2 |
chr13_+_56522497 | 5.54 |
ENSMUST00000045428.6
|
Fbxl21
|
F-box and leucine-rich repeat protein 21 |
chr9_-_110742577 | 5.52 |
ENSMUST00000006005.7
|
Pth1r
|
parathyroid hormone 1 receptor |
chr9_-_59750616 | 5.49 |
ENSMUST00000163586.1
ENSMUST00000177963.1 ENSMUST00000051039.4 |
Senp8
|
SUMO/sentrin specific peptidase 8 |
chr16_-_20621255 | 5.48 |
ENSMUST00000052939.2
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr7_+_44816364 | 5.45 |
ENSMUST00000118125.1
|
Il4i1
|
interleukin 4 induced 1 |
chr16_+_44173271 | 5.43 |
ENSMUST00000088356.4
ENSMUST00000169582.1 |
Gm608
|
predicted gene 608 |
chr2_+_155517948 | 5.42 |
ENSMUST00000029135.8
ENSMUST00000065973.2 ENSMUST00000103142.5 |
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr14_-_31640878 | 5.41 |
ENSMUST00000167066.1
ENSMUST00000127204.2 ENSMUST00000022437.8 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr17_-_45686214 | 5.39 |
ENSMUST00000113523.2
|
Tmem63b
|
transmembrane protein 63b |
chr14_-_61556881 | 5.35 |
ENSMUST00000022497.8
|
Spryd7
|
SPRY domain containing 7 |
chr13_+_54789377 | 5.35 |
ENSMUST00000026993.7
ENSMUST00000131692.2 ENSMUST00000163796.1 |
Tspan17
|
tetraspanin 17 |
chr12_-_104044431 | 5.34 |
ENSMUST00000043915.3
|
Serpina12
|
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
chr5_-_31295862 | 5.32 |
ENSMUST00000041266.7
ENSMUST00000172435.1 |
Fndc4
|
fibronectin type III domain containing 4 |
chr7_-_99626936 | 5.29 |
ENSMUST00000178124.1
|
Gm4980
|
predicted gene 4980 |
chr10_-_128673896 | 5.28 |
ENSMUST00000054764.7
|
Suox
|
sulfite oxidase |
chr11_+_99041237 | 5.27 |
ENSMUST00000017637.6
|
Igfbp4
|
insulin-like growth factor binding protein 4 |
chr5_+_45493374 | 5.26 |
ENSMUST00000046122.6
|
Lap3
|
leucine aminopeptidase 3 |
chr12_+_103532435 | 5.24 |
ENSMUST00000021631.5
|
Ppp4r4
|
protein phosphatase 4, regulatory subunit 4 |
chr18_+_64340225 | 5.23 |
ENSMUST00000175965.2
ENSMUST00000115145.3 |
Onecut2
|
one cut domain, family member 2 |
chr7_-_100658364 | 5.20 |
ENSMUST00000107043.1
|
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr7_-_44816586 | 5.19 |
ENSMUST00000047356.8
|
Atf5
|
activating transcription factor 5 |
chr2_-_73386396 | 5.17 |
ENSMUST00000112044.1
ENSMUST00000112043.1 ENSMUST00000076463.5 |
Gpr155
|
G protein-coupled receptor 155 |
chr17_-_56074542 | 5.17 |
ENSMUST00000139371.1
|
Ubxn6
|
UBX domain protein 6 |
chr17_+_24736673 | 5.15 |
ENSMUST00000101800.5
|
Msrb1
|
methionine sulfoxide reductase B1 |
chr3_-_89393629 | 5.13 |
ENSMUST00000124783.1
ENSMUST00000126027.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr7_-_140154712 | 5.12 |
ENSMUST00000059241.7
|
Sprn
|
shadow of prion protein |
chr11_-_116198701 | 5.11 |
ENSMUST00000072948.4
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr1_+_193153107 | 5.08 |
ENSMUST00000076521.5
|
Irf6
|
interferon regulatory factor 6 |
chr2_-_148045891 | 5.08 |
ENSMUST00000109964.1
|
Foxa2
|
forkhead box A2 |
chr16_-_46496772 | 5.05 |
ENSMUST00000149901.1
ENSMUST00000096052.2 |
Pvrl3
|
poliovirus receptor-related 3 |
chr11_+_75468040 | 5.04 |
ENSMUST00000043598.7
ENSMUST00000108435.1 |
Tlcd2
|
TLC domain containing 2 |
chrX_-_73716145 | 5.03 |
ENSMUST00000002091.5
|
Bcap31
|
B cell receptor associated protein 31 |
chr1_+_131962941 | 5.02 |
ENSMUST00000177943.1
|
Slc45a3
|
solute carrier family 45, member 3 |
chr10_-_80329426 | 5.02 |
ENSMUST00000020340.8
|
Pcsk4
|
proprotein convertase subtilisin/kexin type 4 |
chr15_+_25622525 | 5.02 |
ENSMUST00000110457.1
ENSMUST00000137601.1 |
Myo10
|
myosin X |
chr1_+_191906743 | 5.01 |
ENSMUST00000044954.6
|
Slc30a1
|
solute carrier family 30 (zinc transporter), member 1 |
chr2_+_102658640 | 4.99 |
ENSMUST00000080210.3
|
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr12_-_30373358 | 4.99 |
ENSMUST00000021004.7
|
Sntg2
|
syntrophin, gamma 2 |
chr5_+_33721724 | 4.99 |
ENSMUST00000067150.7
ENSMUST00000169212.2 ENSMUST00000114411.2 ENSMUST00000164207.3 |
Fgfr3
|
fibroblast growth factor receptor 3 |
chr15_-_76660108 | 4.97 |
ENSMUST00000066677.8
ENSMUST00000177359.1 |
Cyhr1
|
cysteine and histidine rich 1 |
chr2_+_31470207 | 4.95 |
ENSMUST00000102840.4
|
Ass1
|
argininosuccinate synthetase 1 |
chr4_-_117133953 | 4.95 |
ENSMUST00000076859.5
|
Plk3
|
polo-like kinase 3 |
chr4_+_136247932 | 4.92 |
ENSMUST00000102533.4
ENSMUST00000143942.1 |
Tcea3
|
transcription elongation factor A (SII), 3 |
chr7_-_44670820 | 4.91 |
ENSMUST00000048102.7
|
Myh14
|
myosin, heavy polypeptide 14 |
chr9_-_86695897 | 4.90 |
ENSMUST00000034989.8
|
Me1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
chr7_-_43489967 | 4.88 |
ENSMUST00000107974.1
|
Iglon5
|
IgLON family member 5 |
chr7_+_44384098 | 4.88 |
ENSMUST00000118962.1
ENSMUST00000118831.1 |
Syt3
|
synaptotagmin III |
chr6_-_119848059 | 4.87 |
ENSMUST00000184864.1
|
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr5_+_130448801 | 4.87 |
ENSMUST00000111288.2
|
Caln1
|
calneuron 1 |
chr4_+_97777606 | 4.83 |
ENSMUST00000075448.6
ENSMUST00000092532.6 |
Nfia
|
nuclear factor I/A |
chr8_-_93197799 | 4.81 |
ENSMUST00000034172.7
|
Ces1d
|
carboxylesterase 1D |
chr11_-_116199040 | 4.81 |
ENSMUST00000066587.5
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr5_+_73491026 | 4.80 |
ENSMUST00000063882.5
ENSMUST00000113558.1 |
Dcun1d4
|
DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae) |
chr4_+_141242850 | 4.77 |
ENSMUST00000138096.1
ENSMUST00000006618.2 ENSMUST00000125392.1 |
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr9_-_108263887 | 4.72 |
ENSMUST00000166905.1
ENSMUST00000080435.2 |
Dag1
|
dystroglycan 1 |
chr17_-_28350600 | 4.71 |
ENSMUST00000114799.1
|
Tead3
|
TEA domain family member 3 |
chr3_-_18243289 | 4.71 |
ENSMUST00000035625.6
|
Cyp7b1
|
cytochrome P450, family 7, subfamily b, polypeptide 1 |
chr5_+_137569851 | 4.68 |
ENSMUST00000031729.8
|
Tfr2
|
transferrin receptor 2 |
chr12_-_108275409 | 4.65 |
ENSMUST00000136175.1
|
Ccdc85c
|
coiled-coil domain containing 85C |
chr6_-_47813512 | 4.64 |
ENSMUST00000077290.7
|
Pdia4
|
protein disulfide isomerase associated 4 |
chr17_-_28350747 | 4.64 |
ENSMUST00000080572.7
ENSMUST00000156862.1 |
Tead3
|
TEA domain family member 3 |
chr6_+_138140521 | 4.63 |
ENSMUST00000120939.1
ENSMUST00000120302.1 |
Mgst1
|
microsomal glutathione S-transferase 1 |
chr19_+_53903351 | 4.61 |
ENSMUST00000025931.6
ENSMUST00000165617.1 |
Pdcd4
|
programmed cell death 4 |
chr11_+_48838672 | 4.61 |
ENSMUST00000129674.1
|
Trim7
|
tripartite motif-containing 7 |
chr4_-_142015056 | 4.59 |
ENSMUST00000105780.1
|
Fhad1
|
forkhead-associated (FHA) phosphopeptide binding domain 1 |
chr4_+_116877376 | 4.58 |
ENSMUST00000044823.3
|
Zswim5
|
zinc finger SWIM-type containing 5 |
chr1_-_121327672 | 4.56 |
ENSMUST00000159085.1
ENSMUST00000159125.1 ENSMUST00000161818.1 |
Insig2
|
insulin induced gene 2 |
chr7_+_140835018 | 4.56 |
ENSMUST00000106050.1
ENSMUST00000026554.4 |
Urah
|
urate (5-hydroxyiso-) hydrolase |
chr4_+_53011916 | 4.54 |
ENSMUST00000107665.3
|
Nipsnap3b
|
nipsnap homolog 3B (C. elegans) |
chr17_+_28858411 | 4.54 |
ENSMUST00000114737.1
ENSMUST00000056866.5 |
Pnpla1
|
patatin-like phospholipase domain containing 1 |
chr11_-_53430779 | 4.52 |
ENSMUST00000061326.4
ENSMUST00000109021.3 |
Uqcrq
|
ubiquinol-cytochrome c reductase, complex III subunit VII |
chr9_+_46269069 | 4.52 |
ENSMUST00000034584.3
|
Apoa5
|
apolipoprotein A-V |
chr5_+_129941949 | 4.52 |
ENSMUST00000051758.7
ENSMUST00000073945.4 |
Vkorc1l1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr9_+_77754526 | 4.51 |
ENSMUST00000034905.8
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit |
chr7_-_81454751 | 4.47 |
ENSMUST00000098331.3
ENSMUST00000178892.1 |
Cpeb1
|
cytoplasmic polyadenylation element binding protein 1 |
chr4_+_138454305 | 4.46 |
ENSMUST00000050918.3
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr19_+_4711153 | 4.44 |
ENSMUST00000008991.6
|
Sptbn2
|
spectrin beta, non-erythrocytic 2 |
chr7_-_30924169 | 4.43 |
ENSMUST00000074671.6
|
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr10_+_93488766 | 4.42 |
ENSMUST00000129421.1
|
Hal
|
histidine ammonia lyase |
chr17_-_34959232 | 4.41 |
ENSMUST00000165202.1
ENSMUST00000172753.1 |
Hspa1b
|
heat shock protein 1B |
chr15_-_3583146 | 4.41 |
ENSMUST00000110698.2
|
Ghr
|
growth hormone receptor |
chr15_-_76198147 | 4.40 |
ENSMUST00000072692.4
|
Plec
|
plectin |
chr3_-_107943390 | 4.39 |
ENSMUST00000106681.1
|
Gstm6
|
glutathione S-transferase, mu 6 |
chr15_+_55112317 | 4.39 |
ENSMUST00000096433.3
|
Deptor
|
DEP domain containing MTOR-interacting protein |
chr16_+_22920222 | 4.38 |
ENSMUST00000023587.4
ENSMUST00000116625.2 |
Fetub
|
fetuin beta |
chr16_+_92058270 | 4.37 |
ENSMUST00000047429.8
ENSMUST00000113975.2 |
Mrps6
Slc5a3
|
mitochondrial ribosomal protein S6 solute carrier family 5 (inositol transporters), member 3 |
chr6_-_116193426 | 4.37 |
ENSMUST00000088896.3
|
Tmcc1
|
transmembrane and coiled coil domains 1 |
chr11_-_74925658 | 4.35 |
ENSMUST00000138612.1
ENSMUST00000123855.1 ENSMUST00000128556.1 ENSMUST00000108448.1 ENSMUST00000108447.1 ENSMUST00000065211.2 |
Srr
|
serine racemase |
chr19_+_46761578 | 4.35 |
ENSMUST00000077666.4
ENSMUST00000099373.4 |
Cnnm2
|
cyclin M2 |
chr2_-_33371400 | 4.34 |
ENSMUST00000113164.1
ENSMUST00000091039.2 ENSMUST00000042615.6 |
Ralgps1
|
Ral GEF with PH domain and SH3 binding motif 1 |
chr4_+_53011880 | 4.33 |
ENSMUST00000015391.3
|
Nipsnap3b
|
nipsnap homolog 3B (C. elegans) |
chrX_-_164027965 | 4.32 |
ENSMUST00000033739.4
|
Car5b
|
carbonic anhydrase 5b, mitochondrial |
chr7_+_101321079 | 4.32 |
ENSMUST00000032927.7
|
Stard10
|
START domain containing 10 |
chr9_-_21927515 | 4.30 |
ENSMUST00000178988.1
ENSMUST00000046831.9 |
Tmem205
|
transmembrane protein 205 |
chr6_-_119848120 | 4.29 |
ENSMUST00000183703.1
ENSMUST00000183911.1 |
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr8_-_123158268 | 4.27 |
ENSMUST00000000755.7
|
Sult5a1
|
sulfotransferase family 5A, member 1 |
chr7_+_44384803 | 4.27 |
ENSMUST00000120262.1
|
Syt3
|
synaptotagmin III |
chr1_-_121327734 | 4.27 |
ENSMUST00000160968.1
ENSMUST00000162582.1 |
Insig2
|
insulin induced gene 2 |
chr3_-_89393294 | 4.27 |
ENSMUST00000142119.1
ENSMUST00000029677.8 ENSMUST00000148361.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr13_+_56522449 | 4.27 |
ENSMUST00000121095.1
ENSMUST00000121871.1 |
Fbxl21
|
F-box and leucine-rich repeat protein 21 |
chr4_-_109202217 | 4.26 |
ENSMUST00000160774.1
ENSMUST00000030288.7 ENSMUST00000162787.2 |
Osbpl9
|
oxysterol binding protein-like 9 |
chr11_+_119942763 | 4.25 |
ENSMUST00000026436.3
ENSMUST00000106231.1 ENSMUST00000075180.5 ENSMUST00000103021.3 ENSMUST00000106233.1 |
Baiap2
|
brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr18_-_56562187 | 4.25 |
ENSMUST00000171844.2
|
Aldh7a1
|
aldehyde dehydrogenase family 7, member A1 |
chr17_-_45685973 | 4.24 |
ENSMUST00000145873.1
|
Tmem63b
|
transmembrane protein 63b |
chr8_-_123158229 | 4.23 |
ENSMUST00000137998.1
|
Sult5a1
|
sulfotransferase family 5A, member 1 |
chr7_+_68275970 | 4.22 |
ENSMUST00000153805.1
|
Fam169b
|
family with sequence similarity 169, member B |
chr3_+_22076644 | 4.22 |
ENSMUST00000063988.8
|
Tbl1xr1
|
transducin (beta)-like 1X-linked receptor 1 |
chr2_+_164960809 | 4.22 |
ENSMUST00000124372.1
|
Slc12a5
|
solute carrier family 12, member 5 |
chr16_+_44173239 | 4.16 |
ENSMUST00000119746.1
|
Gm608
|
predicted gene 608 |
chr16_-_46496955 | 4.16 |
ENSMUST00000023335.6
ENSMUST00000023334.8 |
Pvrl3
|
poliovirus receptor-related 3 |
chr7_-_132576372 | 4.16 |
ENSMUST00000084500.6
|
Oat
|
ornithine aminotransferase |
chr9_+_57697612 | 4.16 |
ENSMUST00000034865.4
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1 |
chr1_+_171419027 | 4.16 |
ENSMUST00000171362.1
|
Tstd1
|
thiosulfate sulfurtransferase (rhodanese)-like domain containing 1 |
chr2_-_3419066 | 4.14 |
ENSMUST00000115082.3
|
Meig1
|
meiosis expressed gene 1 |
chr1_+_166254095 | 4.13 |
ENSMUST00000111416.1
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr5_+_35757875 | 4.13 |
ENSMUST00000101280.3
ENSMUST00000054598.5 ENSMUST00000114205.1 ENSMUST00000114206.2 |
Ablim2
|
actin-binding LIM protein 2 |
chr7_+_28180272 | 4.13 |
ENSMUST00000173223.1
|
Dyrk1b
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
chr7_+_28180226 | 4.09 |
ENSMUST00000172467.1
|
Dyrk1b
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
chr4_-_107307118 | 4.05 |
ENSMUST00000126291.1
ENSMUST00000106748.1 ENSMUST00000129138.1 ENSMUST00000082426.3 |
Dio1
|
deiodinase, iodothyronine, type I |
chr2_+_156065738 | 4.05 |
ENSMUST00000137966.1
|
Spag4
|
sperm associated antigen 4 |
chr8_+_114133601 | 4.02 |
ENSMUST00000109109.1
|
Nudt7
|
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
chr13_-_29984219 | 4.02 |
ENSMUST00000146092.1
|
E2f3
|
E2F transcription factor 3 |
chr17_-_56716788 | 4.01 |
ENSMUST00000067931.5
|
Vmac
|
vimentin-type intermediate filament associated coiled-coil protein |
chr11_+_108920342 | 4.01 |
ENSMUST00000052915.7
|
Axin2
|
axin2 |
chr18_-_66002612 | 3.98 |
ENSMUST00000120461.1
ENSMUST00000048260.7 |
Lman1
|
lectin, mannose-binding, 1 |
chr2_-_160872985 | 3.96 |
ENSMUST00000109460.1
ENSMUST00000127201.1 |
Zhx3
|
zinc fingers and homeoboxes 3 |
chr8_-_13974715 | 3.96 |
ENSMUST00000119182.1
ENSMUST00000062613.4 |
Tdrp
|
testis development related protein |
chr7_-_30973464 | 3.94 |
ENSMUST00000001279.8
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr11_+_90249469 | 3.90 |
ENSMUST00000004050.6
|
Mmd
|
monocyte to macrophage differentiation-associated |
chr7_+_107595051 | 3.90 |
ENSMUST00000040056.7
|
Ppfibp2
|
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr7_-_119895446 | 3.90 |
ENSMUST00000098080.2
|
Dcun1d3
|
DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae) |
chr17_-_57059795 | 3.89 |
ENSMUST00000040280.7
|
Slc25a23
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 |
chr1_-_121327776 | 3.87 |
ENSMUST00000160688.1
|
Insig2
|
insulin induced gene 2 |
chr4_+_9844349 | 3.86 |
ENSMUST00000057613.2
|
Gdf6
|
growth differentiation factor 6 |
chr5_+_117976761 | 3.85 |
ENSMUST00000035579.6
|
Fbxo21
|
F-box protein 21 |
chr1_+_16105774 | 3.84 |
ENSMUST00000027053.7
|
Rdh10
|
retinol dehydrogenase 10 (all-trans) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 18.0 | GO:0048627 | myoblast development(GO:0048627) |
5.3 | 16.0 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
3.8 | 22.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
3.3 | 9.9 | GO:0006507 | GPI anchor release(GO:0006507) |
3.3 | 9.9 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
3.1 | 9.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.9 | 8.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
2.7 | 8.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
2.7 | 8.1 | GO:1903002 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
2.7 | 10.7 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.7 | 10.6 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
2.5 | 10.2 | GO:0030091 | protein repair(GO:0030091) |
2.5 | 9.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
2.4 | 2.4 | GO:1900150 | regulation of defense response to fungus(GO:1900150) |
2.3 | 7.0 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
2.3 | 9.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
2.3 | 6.8 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
2.2 | 12.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.1 | 6.3 | GO:0070602 | regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) |
2.1 | 6.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
2.0 | 6.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
2.0 | 6.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
2.0 | 7.9 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
2.0 | 11.7 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
1.9 | 7.8 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
1.9 | 5.8 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
1.9 | 17.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.9 | 5.8 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
1.9 | 5.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.8 | 5.5 | GO:0015755 | fructose transport(GO:0015755) |
1.8 | 5.5 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
1.8 | 1.8 | GO:0098969 | neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
1.8 | 1.8 | GO:0015744 | succinate transport(GO:0015744) |
1.8 | 10.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
1.8 | 5.3 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
1.8 | 5.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.7 | 8.7 | GO:0015888 | thiamine transport(GO:0015888) |
1.7 | 8.6 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) tyrosine catabolic process(GO:0006572) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.7 | 6.6 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
1.6 | 11.3 | GO:0052805 | imidazole-containing compound catabolic process(GO:0052805) |
1.6 | 6.5 | GO:0032385 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
1.6 | 3.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.6 | 4.8 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
1.6 | 4.7 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
1.6 | 6.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.6 | 7.8 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
1.5 | 6.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.5 | 4.6 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
1.5 | 1.5 | GO:0098661 | inorganic anion transmembrane transport(GO:0098661) |
1.5 | 4.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
1.5 | 4.4 | GO:0034334 | adherens junction maintenance(GO:0034334) |
1.5 | 5.9 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
1.5 | 4.4 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
1.5 | 17.5 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.5 | 4.4 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
1.5 | 1.5 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
1.5 | 7.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.4 | 1.4 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
1.4 | 11.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.4 | 4.3 | GO:0001192 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
1.4 | 14.3 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.4 | 5.7 | GO:1990401 | embryonic lung development(GO:1990401) |
1.4 | 26.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.4 | 1.4 | GO:1905072 | cardiac jelly development(GO:1905072) |
1.4 | 4.1 | GO:0006097 | glyoxylate cycle(GO:0006097) |
1.4 | 4.1 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
1.4 | 2.7 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
1.3 | 5.3 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.3 | 4.0 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
1.3 | 1.3 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
1.3 | 10.5 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.3 | 11.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.3 | 3.9 | GO:0097274 | urea homeostasis(GO:0097274) |
1.3 | 3.9 | GO:1902617 | response to fluoride(GO:1902617) |
1.3 | 3.9 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
1.3 | 6.4 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.3 | 7.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.3 | 3.8 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
1.3 | 5.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.3 | 2.5 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
1.3 | 11.3 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
1.3 | 5.0 | GO:0006001 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.3 | 10.0 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.3 | 10.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.2 | 11.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.2 | 3.7 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.2 | 3.7 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
1.2 | 2.4 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
1.2 | 3.6 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
1.2 | 3.6 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
1.2 | 3.6 | GO:1903919 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
1.2 | 7.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.2 | 7.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.2 | 3.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.2 | 5.9 | GO:0031437 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
1.2 | 10.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.1 | 1.1 | GO:0046710 | GDP metabolic process(GO:0046710) |
1.1 | 1.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
1.1 | 9.1 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
1.1 | 4.6 | GO:0060431 | primary lung bud formation(GO:0060431) |
1.1 | 3.4 | GO:0060365 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) |
1.1 | 7.8 | GO:0030242 | pexophagy(GO:0030242) |
1.1 | 3.4 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.1 | 4.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.1 | 3.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.1 | 25.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
1.1 | 1.1 | GO:0042117 | monocyte activation(GO:0042117) |
1.1 | 6.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.1 | 4.2 | GO:0003360 | brainstem development(GO:0003360) |
1.0 | 1.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.0 | 3.1 | GO:0015866 | ADP transport(GO:0015866) |
1.0 | 3.1 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
1.0 | 1.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.0 | 3.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.0 | 3.0 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
1.0 | 3.0 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
1.0 | 11.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.0 | 8.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.0 | 1.0 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
1.0 | 5.0 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
1.0 | 6.0 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
1.0 | 6.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.0 | 6.9 | GO:0006108 | malate metabolic process(GO:0006108) |
1.0 | 5.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.0 | 12.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.0 | 5.9 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
1.0 | 1.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.0 | 2.9 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
1.0 | 3.9 | GO:0097494 | regulation of vesicle size(GO:0097494) |
1.0 | 2.9 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.0 | 5.8 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.9 | 2.8 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.9 | 3.8 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
0.9 | 8.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.9 | 5.6 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.9 | 3.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.9 | 0.9 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.9 | 2.8 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.9 | 0.9 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
0.9 | 2.8 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.9 | 3.6 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.9 | 1.8 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
0.9 | 11.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.9 | 5.4 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.9 | 3.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.9 | 6.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.9 | 3.6 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.9 | 2.7 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.9 | 3.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.9 | 7.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.9 | 1.8 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.9 | 5.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.9 | 3.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.9 | 2.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.9 | 6.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.9 | 3.5 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
0.9 | 13.8 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.9 | 2.6 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.9 | 4.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.9 | 2.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.9 | 3.4 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.9 | 2.6 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.9 | 2.6 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.9 | 2.6 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.9 | 0.9 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.9 | 1.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.8 | 7.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.8 | 3.4 | GO:0014028 | notochord formation(GO:0014028) |
0.8 | 3.4 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.8 | 5.8 | GO:0015862 | uridine transport(GO:0015862) |
0.8 | 23.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.8 | 2.5 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.8 | 3.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.8 | 0.8 | GO:1901630 | negative regulation of presynaptic membrane organization(GO:1901630) |
0.8 | 4.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.8 | 1.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.8 | 0.8 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.8 | 4.0 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.8 | 3.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.8 | 2.4 | GO:0070342 | brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
0.8 | 3.9 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.8 | 3.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.8 | 6.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.8 | 2.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.8 | 5.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.8 | 2.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.8 | 4.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.8 | 3.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.8 | 2.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.8 | 4.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.8 | 3.8 | GO:0072363 | regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072363) |
0.8 | 6.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 3.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.7 | 3.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.7 | 0.7 | GO:1904173 | regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
0.7 | 7.5 | GO:0015879 | carnitine transport(GO:0015879) |
0.7 | 1.5 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.7 | 2.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.7 | 3.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.7 | 4.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.7 | 12.5 | GO:0072189 | ureter development(GO:0072189) |
0.7 | 3.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.7 | 2.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.7 | 6.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.7 | 8.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.7 | 1.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.7 | 7.3 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.7 | 3.6 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.7 | 2.9 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.7 | 10.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.7 | 15.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.7 | 2.9 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.7 | 0.7 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.7 | 1.4 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) regulation of establishment of T cell polarity(GO:1903903) |
0.7 | 0.7 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.7 | 3.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.7 | 2.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.7 | 2.8 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.7 | 2.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.7 | 1.4 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.7 | 2.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.7 | 3.5 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.7 | 4.8 | GO:0001757 | somite specification(GO:0001757) |
0.7 | 8.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.7 | 2.8 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
0.7 | 2.1 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
0.7 | 1.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.7 | 2.7 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.7 | 2.7 | GO:0014732 | skeletal muscle atrophy(GO:0014732) negative regulation of myoblast fusion(GO:1901740) |
0.7 | 2.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.7 | 2.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.7 | 8.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.7 | 1.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.7 | 8.1 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.7 | 12.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.7 | 3.4 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.7 | 2.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.7 | 6.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.7 | 2.0 | GO:0061193 | taste bud development(GO:0061193) |
0.7 | 4.6 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.7 | 2.0 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.7 | 1.3 | GO:0000050 | urea cycle(GO:0000050) |
0.6 | 1.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.6 | 0.6 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.6 | 6.4 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.6 | 1.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.6 | 0.6 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.6 | 1.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.6 | 4.4 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 5.7 | GO:0060613 | fat pad development(GO:0060613) |
0.6 | 6.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.6 | 3.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.6 | 4.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.6 | 0.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.6 | 2.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.6 | 2.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.6 | 3.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.6 | 1.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.6 | 4.9 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.6 | 4.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.6 | 3.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.6 | 2.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.6 | 3.1 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.6 | 1.8 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.6 | 10.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 4.2 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.6 | 5.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.6 | 2.4 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.6 | 3.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.6 | 1.8 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.6 | 1.2 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.6 | 2.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.6 | 5.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.6 | 1.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.6 | 2.9 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.6 | 2.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.6 | 2.9 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.6 | 6.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.6 | 5.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.6 | 1.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.6 | 1.7 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
0.6 | 8.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 4.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.6 | 0.6 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.6 | 4.0 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.6 | 3.4 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.6 | 1.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.6 | 2.8 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.6 | 26.6 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.6 | 7.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.6 | 3.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 2.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.6 | 2.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.6 | 1.7 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.6 | 1.7 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.6 | 3.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.6 | 0.6 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.6 | 1.1 | GO:2000439 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
0.6 | 0.6 | GO:0021502 | neural fold elevation formation(GO:0021502) |
0.5 | 1.6 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.5 | 1.6 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.5 | 2.2 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.5 | 1.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.5 | 12.4 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.5 | 2.1 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.5 | 0.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.5 | 1.6 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 0.5 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.5 | 2.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.5 | 4.2 | GO:1900194 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.5 | 1.1 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.5 | 1.6 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.5 | 1.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 1.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.5 | 2.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.5 | 3.7 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.5 | 1.0 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.5 | 1.6 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.5 | 3.6 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.5 | 9.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.5 | 1.5 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.5 | 1.5 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.5 | 3.6 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.5 | 1.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.5 | 1.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.5 | 2.6 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 4.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 2.0 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.5 | 2.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.5 | 2.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 3.5 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.5 | 1.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.5 | 0.5 | GO:0010845 | regulation of reciprocal meiotic recombination(GO:0010520) positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.5 | 1.5 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.5 | 2.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.5 | 3.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.5 | 7.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.5 | 8.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.5 | 2.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 8.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.5 | 1.5 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 2.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.5 | 1.5 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.5 | 1.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.5 | 0.5 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 5.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.5 | 1.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.5 | 1.9 | GO:0060416 | response to growth hormone(GO:0060416) |
0.5 | 3.4 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.5 | 1.4 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.5 | 1.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 8.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.5 | 20.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.5 | 2.4 | GO:1990839 | response to endothelin(GO:1990839) |
0.5 | 6.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.5 | 1.4 | GO:0015881 | creatine transport(GO:0015881) |
0.5 | 8.0 | GO:0000338 | protein deneddylation(GO:0000338) |
0.5 | 2.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 1.9 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.5 | 1.4 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
0.5 | 1.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.5 | 1.4 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.5 | 2.8 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.5 | 1.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 1.9 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.5 | 0.9 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.5 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 1.4 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.5 | 6.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 0.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.5 | 6.9 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.5 | 0.9 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.5 | 2.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.5 | 2.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.5 | 6.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.5 | 2.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.5 | 1.8 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.5 | 4.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.5 | 11.4 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.5 | 0.9 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.5 | 1.4 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.5 | 2.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 2.2 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.4 | 2.7 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.4 | 3.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 3.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 5.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 6.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 2.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 1.8 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.4 | 0.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 1.3 | GO:0019405 | alditol catabolic process(GO:0019405) |
0.4 | 7.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.4 | 2.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 1.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.4 | 2.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.4 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.4 | 1.3 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.4 | 2.2 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.4 | 0.9 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.4 | 1.3 | GO:0021843 | substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.4 | 1.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 0.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 0.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 1.7 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.4 | 2.5 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.4 | 3.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.4 | 13.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.4 | 1.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 1.7 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.4 | 0.8 | GO:0021759 | globus pallidus development(GO:0021759) |
0.4 | 1.7 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.4 | 1.2 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.4 | 1.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.4 | 1.2 | GO:0090382 | phagosome maturation(GO:0090382) |
0.4 | 1.2 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
0.4 | 1.7 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.4 | 2.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 1.6 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.4 | 3.3 | GO:0070166 | enamel mineralization(GO:0070166) |
0.4 | 2.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.4 | 3.3 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.4 | 2.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 | 2.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 1.2 | GO:0097475 | motor neuron migration(GO:0097475) |
0.4 | 1.6 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.4 | 1.2 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.4 | 0.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 6.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 2.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.4 | 2.4 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.4 | 1.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 1.6 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.4 | 2.4 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 1.6 | GO:0090282 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.4 | 1.6 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.4 | 4.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.4 | 0.8 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.4 | 1.2 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.4 | 5.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.4 | 3.5 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.4 | 2.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 5.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.4 | 1.1 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.4 | 2.7 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.4 | 1.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.4 | 1.1 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.4 | 1.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 1.1 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.4 | 4.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 1.9 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.4 | 1.5 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.4 | 1.5 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.4 | 3.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.4 | 1.9 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 0.8 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.4 | 0.8 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.4 | 1.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 0.7 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 0.7 | GO:0045818 | negative regulation of glycogen catabolic process(GO:0045818) |
0.4 | 1.1 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.4 | 5.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.4 | 1.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 2.2 | GO:0098792 | xenophagy(GO:0098792) |
0.4 | 1.1 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.4 | 0.7 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.4 | 0.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 1.5 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.4 | 4.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.4 | 1.1 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.4 | 2.5 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.4 | 1.4 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.4 | 1.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.4 | 1.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.4 | 0.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.4 | 1.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 2.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.4 | 0.4 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.4 | 1.1 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.4 | 1.4 | GO:0072014 | proximal tubule development(GO:0072014) |
0.3 | 2.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 0.7 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 0.3 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.3 | 0.7 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.3 | 1.0 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 4.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 3.8 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 1.0 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.3 | 1.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.3 | 1.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.3 | 0.7 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 0.7 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.3 | 1.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 0.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 2.0 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.3 | 1.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 1.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 1.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 1.0 | GO:0021998 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) positive regulation of cardiac ventricle development(GO:1904414) |